KPRX logo

Kiora Pharmaceuticals (KPRX) Shareholders Equity

Annual Shareholders Equity

$6.11 M
-$5.30 M-46.44%

December 1, 2023


Summary


Performance

KPRX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPRXbalance sheetmetrics:

Quarterly Shareholders Equity

$30.03 M
-$3.07 M-9.28%

September 1, 2024


Summary


Performance

KPRX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPRXbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KPRX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-46.4%+270.6%
3 y3 years-37.2%+120.1%
5 y5 years-31.6%+120.1%

KPRX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-58.1%at low-14.0%+391.5%
5 y5-year-58.1%at low-14.0%+403.7%
alltimeall time-58.1%+113.0%-14.0%+164.1%

Kiora Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$30.03 M(-9.3%)
Jun 2024
-
$33.10 M(-5.2%)
Mar 2024
-
$34.90 M(+471.3%)
Dec 2023
$6.11 M(-46.4%)
$6.11 M(-24.6%)
Sep 2023
-
$8.10 M(-40.6%)
Jun 2023
-
$13.64 M(+34.3%)
Mar 2023
-
$10.16 M(-11.0%)
Dec 2022
$11.41 M(-21.8%)
$11.41 M(+8.4%)
Sep 2022
-
$10.52 M(+20.1%)
Jun 2022
-
$8.76 M(-22.2%)
Mar 2022
-
$11.26 M(-22.8%)
Dec 2021
$14.58 M(+49.8%)
$14.58 M(-16.0%)
Sep 2021
-
$17.35 M(+65.9%)
Jun 2021
-
$10.45 M(-17.6%)
Mar 2021
-
$12.69 M(+30.4%)
Dec 2020
$9.73 M(+46.9%)
$9.73 M(+63.2%)
Sep 2020
-
$5.96 M(-23.5%)
Jun 2020
-
$7.80 M(-16.3%)
Mar 2020
-
$9.32 M(+40.7%)
Dec 2019
$6.62 M
$6.62 M(+27.1%)
Sep 2019
-
$5.21 M(-38.5%)
Jun 2019
-
$8.47 M(-15.6%)
DateAnnualQuarterly
Mar 2019
-
$10.04 M(+12.3%)
Dec 2018
$8.94 M(-563.8%)
$8.94 M(-19.5%)
Sep 2018
-
$11.10 M(-18.1%)
Jun 2018
-
$13.55 M(+156.7%)
Mar 2018
-
$5.28 M(-373.9%)
Dec 2017
-$1.93 M(+485.0%)
-$1.93 M(-383.6%)
Sep 2017
-
$679.40 K(-85.1%)
Jun 2017
-
$4.57 M(-498.6%)
Mar 2017
-
-$1.15 M(+248.0%)
Dec 2016
-$329.40 K(-105.4%)
-$329.40 K(-110.1%)
Sep 2016
-
$3.25 M(-49.8%)
Jun 2016
-
$6.47 M(-3.0%)
Mar 2016
-
$6.67 M(+9.5%)
Dec 2015
$6.09 M(-113.0%)
$6.09 M(-29.9%)
Sep 2015
-
$8.68 M(+849.7%)
Jun 2015
-
$913.70 K(-57.2%)
Mar 2015
-
$2.13 M(-104.6%)
Dec 2014
-$46.81 M(+4.4%)
-$46.81 M(+1.1%)
Sep 2014
-
-$46.30 M(-1.2%)
Jun 2014
-
-$46.85 M(+2.6%)
Mar 2014
-
-$45.64 M(+1.8%)
Dec 2013
-$44.84 M(+8.9%)
-$44.84 M
Dec 2012
-$41.16 M
-

FAQ

  • What is Kiora Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Kiora Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Kiora Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of KPRX is $6.11 M

What is the all time high annual shareholders equity for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high annual stockholders equity is $14.58 M

What is Kiora Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, KPRX annual stockholders equity has changed by -$5.30 M (-46.44%)

What is Kiora Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of KPRX is $30.03 M

What is the all time high quarterly shareholders equity for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high quarterly stockholders equity is $34.90 M

What is Kiora Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, KPRX quarterly stockholders equity has changed by +$21.93 M (+270.56%)